Status:
UNKNOWN
A Clinical tRial of Endobronchial Ultrasound for the Diagnosis of MEDiastinal lymphadenopathY (REMEDY)
Lead Sponsor:
University College London Hospitals
Conditions:
Isolated Mediastinal Lymphadenopathy
Sarcoidosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Enlarged glands in the chest (mediastinal lymphadenopathy) is a common problem and may have a variety of different causes. In the past an operation (mediastinoscopy) was required to diagnose the gland...
Detailed Description
Although the literature is replete with data on the utility of Endobronchial Ultrasound for lung cancer, there are very few data available on its role in the diagnosis of isolated mediastinal lymphade...
Eligibility Criteria
Inclusion
- Consecutive patients with undiagnosed mediastinal lymphadenopathy (\>1cm in short axis) on CT or PET-CT scan for whom pathological evaluation is clinically indicated.
Exclusion
- Patients without informed consent, those with anterior mediastinal lesions or with contra-indications to EBUS or mediastinoscopy will be excluded.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00932854
Start Date
July 1 2009
End Date
October 1 2011
Last Update
October 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London Hospital
London, London, United Kingdom, WC1E 5DB